Cargando…
An Episode of Pseudothrombocytopenia during Pembrolizumab Therapy in NSCLC Patient
Immunotherapy with immune checkpoint inhibitors (ICI) is a new option of treatment in a growing range of neoplasms. In addition to an antitumor effect, ICI are associated with autoimmune reactions resulting in a wide spectrum of toxicities that have not been seen in patients receiving chemotherapy....
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232686/ https://www.ncbi.nlm.nih.gov/pubmed/32455036 http://dx.doi.org/10.1155/2020/4196178 |